Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal cell carcinoma.

J H Reese1

  • 1Santa Clara Valley Medical Center, San Jose, California.

Current Opinion in Oncology
|June 1, 1992
PubMed
Summary

Renal cell carcinoma is unpredictable, especially when metastatic. Research focuses on genetic changes, immunotherapy combinations, and surgical approaches to better control this challenging genitourinary cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Necrotizing sarcoidosis of the kidney presenting as a renal mass.

BJU international·2009
Same author

Poorly differentiated carcinoma of bladder producing granulocyte colony-stimulating factor and parathyroid hormone related protein.

The Journal of urology·2001
Same author

Clinical and radiological findings in patients with gas forming renal abscess treated conservatively.

The Journal of urology·1999
Same author

Effect of montelukast on single-dose theophylline pharmacokinetics.

American journal of therapeutics·1999
Same author

Endoscopic management of upper tract urothelial tumors.

Techniques in urology·1998
Same author

A study of the interaction between dirithromycin and astemizole in healthy adults.

American journal of therapeutics·1997

Area of Science:

  • Oncology
  • Genitourinary Neoplasms

Background:

  • Renal cell carcinoma (RCC) exhibits unpredictable behavior, particularly in its metastatic stages.
  • Controlling widespread RCC beyond the kidney presents significant clinical challenges.

Purpose of the Study:

  • To review recent advancements in understanding and treating metastatic renal cell carcinoma.
  • To highlight the role of cytogenetic changes, immunotherapy, and surgical interventions.

Main Methods:

  • Review of current literature on renal cell carcinoma treatment.
  • Analysis of studies focusing on cytogenetic and chromosomal alterations.
  • Examination of immunotherapy combinations (interferons, interleukin-2) and surgical techniques.

Main Results:

  • Cytogenetic and chromosomal changes offer partial explanations for RCC's behavior.
  • Immunotherapy combinations show promise in managing metastatic disease.
  • Surgical strategies, including parenchyma-sparing operations and vena cava tumor management, are under ongoing investigation.

Conclusions:

  • Understanding genetic alterations is key to deciphering RCC's behavior.
  • Combination immunotherapy is a primary nonsurgical treatment for metastatic RCC.
  • Evolving surgical techniques continue to be evaluated for optimal patient outcomes in complex RCC cases.

Related Experiment Videos